Desmoid Tumors Market Challenges: Addressing Diagnosis Delays and Access to Specialized Care.
The Problem of Misdiagnosis and Prolonged Diagnostic Journeys
One of the most enduring challenges in the desmoid tumors market is the significant delay in diagnosis. Given the rarity of the disease, it is frequently mistaken for more common soft tissue masses, such as hematomas or benign fibrous lesions. This leads to prolonged diagnostic journeys, sometimes lasting over a year, during which...
0 Comments
0 Shares
303 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt